Halpride M2 Forte Tablet is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, enhancing glucose uptake in muscle tissues. The synergistic effect of these two agents provides improved glycemic control in patients inadequately controlled with diet and exercise alone or monotherapy. Halpride M2 Forte is typically prescribed as part of a comprehensive treatment plan including diet modification, physical activity, and regular blood glucose monitoring. Its use helps in reducing the risk of diabetes-related complications such as neuropathy, nephropathy, and retinopathy. Caution is advised in patients with renal impairment, hepatic dysfunction, or a history of lactic acidosis. Common adverse effects may include gastrointestinal disturbances, hypoglycemia, and weight gain. Regular monitoring of blood glucose levels and periodic assessment of renal function are recommended during therapy. Halpride M2 Forte should be used under medical supervision to optimize therapeutic outcomes and minimize potential risks.